Download Free Medical MENOPAUSE and HRT PowerPoint Presentation

MENOPAUSE and HRT PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Check out this medical presentation on Obstetrics & Gynecology, which is titled "MENOPAUSE & HRT", to know about Menopause.

Tags : Obstetrics, Gynecology, MENOPAUSE, HRT

Published on : Jul 18, 2021 | Views : 3131 | Downloads : 8

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

MENOPAUSE & HRT Nicola Stewart 28/02/2018
Slide 2-

Physiology & Clinical Features 1.5 million oocytes at birth. 1/3rd lost by menarche. Peri-menopause – increased anovulatory cycles. Clinical Features: (affects 2/3rd woman) Menstrual irregularity Vasomotor Musculoskeletal Psychological Urogenital Cardiovascular Osteoporosis Breast disease
Slide 3-

Case Study 1 43 year old Mirena coil for 2 years Presenting with: Inter menstrual and post coital bleeding Increased anxiety, snapping No hot flushes or night sweats, not low in mood, no change to libido No FH of early menopause Asking if she is peri-menopausal? Asking to have a blood test?
Slide 4-

Diagnosis Diagnosis should be based on clinical symptoms if >45 Perimenopause – vasomotor Sx & irregular periods Menopause – no period for 12m & not taking contraception (Sx if no uterus) Consider FSH if… >45 years with atypical symptoms 40-45 years with Sx and change in periods <45 years and suspecting premature menopause Laboratory results Consistently raised FSH >30IU/l. Raised LH Low serum oestrdiol.
Slide 5-

Assessment of Menopause Assess symptoms and their severity Assess risk of cardiovascular disease (Qrisk) Assess risk of osteoporosis Discuss her expectations Only carry out investigations if… Sudden change in menstrual pattern (IMB, post coital) Personal or FH of DVT High risk of breast cancer Evidence of arterial of other gynaecological disease
Slide 6-

Case Study 2 34 year old Has not had a period for 7 months FH of premature menopause Nil other symptoms Asking if she should be tested for this? Asking what management might be required?
Slide 7-

Premature Menopause Menopause <40 years (1%). Risk of osteoporosis and IHD Diagnosis – FSH >30 with raised LH and low oestrogen on two occasions 4-6 weeks apart Management Should have hormonal treatment with HRT or combined hormonal contraceptive until age of natural menopause & 5-10 yrs after HRT can benefit BP/ CVS risks, but both HRT and combined contraceptive offer bone protection. HRT not a contraceptive
Slide 8-

Case Study 3 52 year old Suffering from hot flushes, night sweats and loss of libido Last period was 8 months ago Would like to discuss HRT. Benefits and risks? If there are things she can also adjust herself? What she should start?
Slide 9-

HRT Indications Relief of vasomotor or other menopausal symptoms Prevention of osteoporosis Premature ovarian failure Contraindications Pregnancy, undiagnosed abnormal PV bleeding Active thromboembolic disorder or MI Breast disease or endometrial cancer Active liver disease
Slide 10-

HRT Modifiable lifestyle factors Healthy balanced diet Calcium supplements Smoking, alcohol and caffeine Optimise management of their co-morbidities Benefits Reduce vasomotor symptoms Improved sleep, joint pain, quality of life Reduced psychological symptoms Reduce vaginal dryness and improve sexual function Improve bone mineral density
Slide 11-

Counselling Points Irregular bleeding is common in first 3-6 months (Bleeding > 6mnths/ after amenorrhoea requires Ix) Importance of adherence with treatment Remind peri-menopausal women that HRT is not a contraceptive Can stop contraception at 1 year after period if >50 yrs and 2 years if <50yrs or 56yrs No evidence that HRT causes weight gain
Slide 12-

Risks (over 5 years) Breast cancer <50yrs on HRT no extra risk Background risk is 15/1000. 2-6/1000 extra cases Ovarian cancer Background risk is 2/1000. <1 extra case over 5 yrs Endometrial cancer Combined HRT protects endometrium B/G risk is 2/1000. 4 extra cases over 5 yrs (oestrogen only) Venous thromboembolism Background risk is 5/1000. 2 extra cases over 5 yrs Cardiovascular disease No increased risks
Slide 13-

Risks (in perspective) Breast cancer <>2-3 units alcohol per day increases risk by 1.5x Post menopausal obesity increases risk by 1.6x First pregnancy >30 years increases risk by 1.9x 5 years of HRT increases risk by 1.35x
Slide 14-

Management Algorithm HRT Guidance and Treatment Pathway
Slide 15-

Case Study 4 54 yr old has read the PIL on HRT and decided that she does not want to accept the potential risks. Suffers from hot flushes and would like to know what she can try? Finding sex uncomfortable, would like to know what she can try?
Slide 16-

Alternative Treatments Vasomotor symptoms Fluoxetine, citalopram, venlafaxine or clonidine Vaginal dryness Vaginal lubricants Sexual dysfunction Seek specialist advice re; testosterone Psychological symptoms CBT, antidepressants Tibolone Beta blockers, gabapentin, complementary therapies
Slide 17-

Case Study 5 57 year old Menopausal symptoms LMP: 2 yrs ago. PMH: DVT following laparotomy. Asking if she can start HRT?
Slide 18-

Management of Co-Morbidities With or high risk of breast cancer Non-hormonal and non-pharmacological treatment St Johns Wart (Tamoxifen) Refer for further specialist input Risk of VTE Transdermal rather than oral Refer to haematologist if high risk Cardiovascular disease Can use HRT. Manage risk factors Type 2 diabetes Can use HRT. No effect of glucose control
Slide 19-

Case Study 6 51 year old Presenting with mastodynia (worse over 3-4 months) and symptoms of hot flushes, night sweats and tearfulness Estradiol for 15 months. Mirena for 3 years. No periods Has tried St Johns Wort and primrose oil What options would you give her?
Slide 20-

Poor Symptom Control Check compliance and allow time Usually 3 months before making any changes Poor patch adhesion or skin irritation Change brand Inadequate oestrogen dose Increase dose or change route Unrealistic expectations Counsel Drug interactions
Slide 21-

Side Effects
Slide 22-

When to Refer Persistent side effects Difficulty in diagnosis Loss of libido causing significant distress Premature menopause Patient request Difficulty in knowing when to stop HRT (usually consider at 5 yrs as they enter menopause) Complex medical history
Slide 23-

Review Follow up at 3 months Then annual review Effectiveness, s/e, dose, route, pros and cons BP, cervical and breast screening, osteoporosis Roughly for around 5 years after onset of symptoms There is no mandatory limitations HRT should be withdrawn slowly